health

Massive hope for pancreatic cancer pill after trial saw tumours vanish

Massive hope for pancreatic cancer pill after trial saw tumours vanish

Daily pill daraxonrasib appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest cancers.

Experts are calling it the biggest breakthrough in pancreatic cancer treatment for decades - a daily pill that appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest and hardest-to-treat cancers.

Cancer became undetectable on scans in one in 12 of the patients given daraxonrasib along with chemotherapy in early medical trials.

Tumours stopped growing in almost all of the 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body.

But doctors stress it is unclear how long it might keep the disease at bay and should not be seen as a cure.

Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients.

The charity's Dr Sam Godfrey told BBC News that the results were incredibly exciting. "What this new drug has done is it's found a way of drugging the undruggable.

"We are finally seeing progress in pancreatic cancer which is so long overdue."

Pancreatic cancer is notoriously hard to treat and has the lowest survival rate of all common cancers in the UK.

Although chemotherapy can shrink tumours a bit, the cancer often grows again.

Most patients with advanced disease survive months, not years.

Doctors hope the new treatment might offer patients more time, even if it cannot stop cancers for good.

The trial followed patients for a year and a half, on average, and some did not see their cancer return during this time.

Longer studies are needed to understand if any of these cancers can be put into remission and for how long.

tumours stopped growing in 90% of patients

just over 60% of patients saw their tumours shrink or disappear

for around 8% of patients, or one in 12, tumours became undetectable on CT scans

Dr Wungki Park, from Memorial Sloan Kettering Cancer Center in the US and who is involved in the trial, said the results were extremely encouraging so far.

"We are beginning to see not only a higher percentage of tumour response rates, but also deeper responses and a near doubling in the duration of disease control, which may eventually translate into longer survival," he said.

Daraxonrasib is a targeted inhibitor treatment that has already been approved in the US. It works by locking on to and shutting off certain mutations, called RAS, found in most pancreatic cancers that drive tumour growth.

Dozens of other cancers, including lung and ovarian, can have similar mutations, meaning the drug might help lots of other patients too.

Dr Godfrey said: "I would hope that the early success that we are beginning to see in pancreatic cancer can also be rolled out to other cancers."

He said longer trials and results were vital. "Cancer can come back and even if scans show there is no sign of it, you don't necessarily know you are cancer-free until more time has passed."

Prof Elena Garralda, chair of a European cancer conference called EORTC–NCI–AACR Symposium 2026 where the work is being presented to other doctors, said: "These results are exciting because they show the combined treatment could potentially significantly improve patients' overall survival, as well as the time before tumours start to grow again."

Pancreatic cancer accounts for about 3% of all cancers in the United States and about 8% of all cancer deaths, killing around 53,000 people a year.

In Britain, there are 11,500 diagnoses of the disease each year and around 10,200 deaths, according to Cancer Research UK.

Actor Alan Rickman died of the disease in 2016, five months after diagnosis.

Symptoms can include jaundice, itchy skin, darker pee, paler poo, unexplained weight loss, tiredness and high temperature.

Do you have any questions about the issues raised in this story, or have you been affected by them?

Daily pill doubles survival time for pancreatic cancer patients

  • cancer
  • pill
  • hope
  • trial
  • tumour
  • daily
  • daraxonrasib
  • patient

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’
health

Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’

Cancer undetectable for one in 12 patients in daraxonrasib trial, while nearly all participants’ tumours stopped growing A pill that can shrink and potentially eliminate pancreas tumours is being hailed as the biggest breakthrough treatment for the cancer in decades. In one in 12 of the patients given the drug, daraxonrasib, during a trial, the cancer became undetectable, and the tumours stopped growing in almost all of the 61 patients.

Read →
Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds
health

Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds

Trust apologises after findings on treatment of 20 brain tumour patients under oncologist who retired in 2023 Cancer patients were severely harmed after being given years of unnecessary chemotherapy treatment by an NHS trust, a report has found. Some people were misdiagnosed and given inappropriate courses of treatment, while others were incorrectly told that if they stopped chemotherapy they would die, according to a Royal College of Physicians (RCP) report.

Read →
Doctor whose evidence helped to convict Lucy Letby was barred from treating patients during trial
health

Doctor whose evidence helped to convict Lucy Letby was barred from treating patients during trial

Exclusive: Jury was never told that Prof Peter Hindmarsh was barred from practising over concerns for patients’ safety A senior doctor whose evidence helped to convict Lucy Letby and who was held up by prosecutors as a pre-eminent expert was barred from treating patients during the trial over fears he posed a risk to their safety. Prof Peter Hindmarsh, a specialist in hormones in children, was crucial to the crown’s argument that Letby had poisoned children by injecting insulin into fluid bags.

Read →
Call for police to investigate Scottish hospital after 19 deaths due to surgery
health

Call for police to investigate Scottish hospital after 19 deaths due to surgery

Surgeon at Aberdeen Royal Infirmary says he repeatedly voiced concerns that patients may have died unnecessarily A senior surgeon has called for a criminal investigation into a Scottish hospital after it emerged that at least 19 patients had died from avoidable complications due to surgery. Dr Mohammed Habib, a consultant at Aberdeen Royal Infirmary, said he had repeatedly reported concerns about the hospital’s liver and pancreatic surgery from 2021 onwards and believed dozens of patients may have died unnecessarily there.

Read →
‘I know what that hope feels like’ – New York City Mayor Mamdani on Javits’ immigrant journey
health

‘I know what that hope feels like’ – New York City Mayor Mamdani on Javits’ immigrant journey

New York City Mayor Zohran Kwame Mamdani has drawn parallels between his childhood journey from Africa to the United States and that of 15-year-old Badu Nkansah Frimpong, popularly known as Javits, whose funeral was held in the Bronx on Friday. “Like Javits, I travelled to this city from Africa as a child, landing at JFK full of excitement and nerves, eager to find my place in this vast city,” he said.

Read →